Meropenem resistance in pseudomonas aeruginosa

Yoshihiro Sumita, M. Fukasawa

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Two genetically distinct classes of meropenem-low-susceptibility Pseudomonas oaeruginosa PA02152 mutants, which arose spontaneously, were isolated. Two meropenem resistance genes, mpmA and mpmB, were mapped near ilvB/C and proC, respectively, on the P. aeruginosa PAO chromosome. The mpmA was thought to be identical to oprD2 because of the cross-resistance to carbapenems and the association with the loss of the outer membrane protein D2 (OprD2). The mpmB mutation conferred a 4-fold increase in resistance to meropenem, and cross-resistance to various types of antimicrobial agents, e.g. carbenicillin, norfloxacin and chloramphenicol. However, the mpmB mutant was susceptible to imipenem. This mutant still possessed OprD2 and showed increased expression of a 48-kD outer membrane protein, although its profiles of β-lactamase activity and affinities of penicillin-binding proteins for β-lactams were indistinguishable from those of the parent strain. The resistance gene mpmB was considered to be an allele of nalB (or cfxB or oprK) from the results of the transductional analysis. The mutation frequency of mpmA:mpmB was in the ratio of 4:1. The same results were obtained in another clinically isolated P. aeruginosa strain. Meropenem resistance caused by both mpmA and mpmB mutations seemed to be due to the reduction in permeability of antibiotics through the outer membrane. These findings suggest a new pathway for the translocation of meropenem other than that mediated by OprD2 across the outer membrane. Thus, meropenem showed about 4- to 8-fold higher activity than imipenem against OprD2-deficient P. aeruginosa.

Original languageEnglish
Pages (from-to)47-56
Number of pages10
JournalChemotherapy
Volume42
Issue number1
DOIs
Publication statusPublished - Jan 1 1996
Externally publishedYes

Fingerprint

meropenem
Pseudomonas aeruginosa
Membrane Proteins
Imipenem
Carbenicillin
Penicillin-Binding Proteins
Lactams
Norfloxacin
Mutation
Carbapenems
Membranes
Mutation Rate
Chloramphenicol
Anti-Infective Agents
Pseudomonas
Genes
Permeability
Chromosomes
Alleles
Anti-Bacterial Agents

Keywords

  • Carbapenems
  • Pseudomonas aeruginosa
  • Resistance

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Drug Discovery
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Meropenem resistance in pseudomonas aeruginosa. / Sumita, Yoshihiro; Fukasawa, M.

In: Chemotherapy, Vol. 42, No. 1, 01.01.1996, p. 47-56.

Research output: Contribution to journalArticle

Sumita, Y & Fukasawa, M 1996, 'Meropenem resistance in pseudomonas aeruginosa', Chemotherapy, vol. 42, no. 1, pp. 47-56. https://doi.org/10.1159/000239421
Sumita, Yoshihiro ; Fukasawa, M. / Meropenem resistance in pseudomonas aeruginosa. In: Chemotherapy. 1996 ; Vol. 42, No. 1. pp. 47-56.
@article{8113405f4df34d4db5eab29151c3fd60,
title = "Meropenem resistance in pseudomonas aeruginosa",
abstract = "Two genetically distinct classes of meropenem-low-susceptibility Pseudomonas oaeruginosa PA02152 mutants, which arose spontaneously, were isolated. Two meropenem resistance genes, mpmA and mpmB, were mapped near ilvB/C and proC, respectively, on the P. aeruginosa PAO chromosome. The mpmA was thought to be identical to oprD2 because of the cross-resistance to carbapenems and the association with the loss of the outer membrane protein D2 (OprD2). The mpmB mutation conferred a 4-fold increase in resistance to meropenem, and cross-resistance to various types of antimicrobial agents, e.g. carbenicillin, norfloxacin and chloramphenicol. However, the mpmB mutant was susceptible to imipenem. This mutant still possessed OprD2 and showed increased expression of a 48-kD outer membrane protein, although its profiles of β-lactamase activity and affinities of penicillin-binding proteins for β-lactams were indistinguishable from those of the parent strain. The resistance gene mpmB was considered to be an allele of nalB (or cfxB or oprK) from the results of the transductional analysis. The mutation frequency of mpmA:mpmB was in the ratio of 4:1. The same results were obtained in another clinically isolated P. aeruginosa strain. Meropenem resistance caused by both mpmA and mpmB mutations seemed to be due to the reduction in permeability of antibiotics through the outer membrane. These findings suggest a new pathway for the translocation of meropenem other than that mediated by OprD2 across the outer membrane. Thus, meropenem showed about 4- to 8-fold higher activity than imipenem against OprD2-deficient P. aeruginosa.",
keywords = "Carbapenems, Pseudomonas aeruginosa, Resistance",
author = "Yoshihiro Sumita and M. Fukasawa",
year = "1996",
month = "1",
day = "1",
doi = "10.1159/000239421",
language = "English",
volume = "42",
pages = "47--56",
journal = "Chemotherapy",
issn = "0009-3165",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Meropenem resistance in pseudomonas aeruginosa

AU - Sumita, Yoshihiro

AU - Fukasawa, M.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Two genetically distinct classes of meropenem-low-susceptibility Pseudomonas oaeruginosa PA02152 mutants, which arose spontaneously, were isolated. Two meropenem resistance genes, mpmA and mpmB, were mapped near ilvB/C and proC, respectively, on the P. aeruginosa PAO chromosome. The mpmA was thought to be identical to oprD2 because of the cross-resistance to carbapenems and the association with the loss of the outer membrane protein D2 (OprD2). The mpmB mutation conferred a 4-fold increase in resistance to meropenem, and cross-resistance to various types of antimicrobial agents, e.g. carbenicillin, norfloxacin and chloramphenicol. However, the mpmB mutant was susceptible to imipenem. This mutant still possessed OprD2 and showed increased expression of a 48-kD outer membrane protein, although its profiles of β-lactamase activity and affinities of penicillin-binding proteins for β-lactams were indistinguishable from those of the parent strain. The resistance gene mpmB was considered to be an allele of nalB (or cfxB or oprK) from the results of the transductional analysis. The mutation frequency of mpmA:mpmB was in the ratio of 4:1. The same results were obtained in another clinically isolated P. aeruginosa strain. Meropenem resistance caused by both mpmA and mpmB mutations seemed to be due to the reduction in permeability of antibiotics through the outer membrane. These findings suggest a new pathway for the translocation of meropenem other than that mediated by OprD2 across the outer membrane. Thus, meropenem showed about 4- to 8-fold higher activity than imipenem against OprD2-deficient P. aeruginosa.

AB - Two genetically distinct classes of meropenem-low-susceptibility Pseudomonas oaeruginosa PA02152 mutants, which arose spontaneously, were isolated. Two meropenem resistance genes, mpmA and mpmB, were mapped near ilvB/C and proC, respectively, on the P. aeruginosa PAO chromosome. The mpmA was thought to be identical to oprD2 because of the cross-resistance to carbapenems and the association with the loss of the outer membrane protein D2 (OprD2). The mpmB mutation conferred a 4-fold increase in resistance to meropenem, and cross-resistance to various types of antimicrobial agents, e.g. carbenicillin, norfloxacin and chloramphenicol. However, the mpmB mutant was susceptible to imipenem. This mutant still possessed OprD2 and showed increased expression of a 48-kD outer membrane protein, although its profiles of β-lactamase activity and affinities of penicillin-binding proteins for β-lactams were indistinguishable from those of the parent strain. The resistance gene mpmB was considered to be an allele of nalB (or cfxB or oprK) from the results of the transductional analysis. The mutation frequency of mpmA:mpmB was in the ratio of 4:1. The same results were obtained in another clinically isolated P. aeruginosa strain. Meropenem resistance caused by both mpmA and mpmB mutations seemed to be due to the reduction in permeability of antibiotics through the outer membrane. These findings suggest a new pathway for the translocation of meropenem other than that mediated by OprD2 across the outer membrane. Thus, meropenem showed about 4- to 8-fold higher activity than imipenem against OprD2-deficient P. aeruginosa.

KW - Carbapenems

KW - Pseudomonas aeruginosa

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=0029655920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029655920&partnerID=8YFLogxK

U2 - 10.1159/000239421

DO - 10.1159/000239421

M3 - Article

C2 - 8751266

AN - SCOPUS:0029655920

VL - 42

SP - 47

EP - 56

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3165

IS - 1

ER -